A semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms.
For prophylaxis and treatment of bacterial infections.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.